BIVALIRUDIN VERSUS HEPARIN MONOTHERAPY IN PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: AN ANALYSIS OF ACUTE ADVERSE OUTCOMES AND COST

Bivalirudin compared with heparin has been shown to reduce rates of bleeding and death in patients undergoing primary percutaneous coronary intervention (PCI). In light of recent evidence, this study compares the acute outcomes and cost in a contemporary population of patients with ST elevation